Introduction - GLP-1 receptor agonists and CV risk management in type 2 diabetes: a new treatment paradigm?
28 August 2017 (12:45 - 12:55)
Organised by:
About the speaker
Karolinska Institute, Stockholm (Sweden)
3 More presentations in this session
Professor L. Ryden (Stockholm, SE)
Professor M. Pfeffer (Boston, US)
Doctor M. Husain (Toronto, CA)
Access the full session
The Event
ESC Congress 2017
28 August 2017
12:45 CET
